Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease ...

Heart disease is expected to affect 61% of US adults by 2050, so it’s important to know when problems may be afoot.

Abbott has unveiled positive long-term data for its Esprit below-the-knee (BTK) stent in treating the most severe form of peripheral artery disease (PAD). The data, which was presented as a ...

Learn about Peripheral Artery Disease (PAD) and its impact on the Black community. Discover the risks, symptoms, and treatment options for this irreversible medical condition.

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a ...

Gains from its Bitcoin holdings contributed notably to EPS growth. Semler Scientific produces the QuantaFlo -- a non-invasive ...

Johnson & Johnson MedTech's Shockwave Medical unit today announced the first clinical outcomes associated with its Javelin ...

Royal Philips announced enrollment of the first patient in THOR, a United States investigational device exemption (IDE) clinica ...

What is Peripheral Vascular Disease? Symptoms and Causes Explained - Peripheral Vascular Disease, PVD for short, is a ...

Coronary artery disease is the silent killer because you can have it for years and have no symptoms until it’s too late.

This is the first hospital in North Texas to offer the treatment for patients suffering from complex peripheral artery ...